Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec;267(1-2):209-14.
doi: 10.1023/b:mcbi.0000049385.13773.23.

Remedial effect of DL-alpha-lipoic acid against adriamycin induced testicular lipid peroxidation

Affiliations

Remedial effect of DL-alpha-lipoic acid against adriamycin induced testicular lipid peroxidation

Chidambaram Prahalathan et al. Mol Cell Biochem. 2004 Dec.

Abstract

Adriamycin (ADR), a cytotoxic antineoplastic drug is used in the treatment of various solid tumors. However, its efficacy continues to be challenged by significant toxicities including testicular toxicity. In the present study, the effect of lipoic acid, a "universal antioxidant" was investigated on ADR induced peroxidative damages in rat testis. Adult male albino rats of Wistar strain were administered ADR (1 mg/kg body weight, i.v.) once a week for 10 weeks. ADR injected rats showed a significant decline in the activities of enzymic antioxidants (catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase and glutathione-S-transferase) and non-enzymic antioxidants (reduced glutathione, Vitamin A, Vitamin C and Vitamin E) with high malondialdehyde levels. The extent of testicular toxicity was evident from the decreased activities of testicular marker enzymes (sorbitol dehydrogenase and glucose-6-phosphate dehydrogenase). Treatment with lipoic acid (35 mg/kg body weight, i.p.) one day prior to ADR administration, maintained near normal activities of the enzymes and significantly reduced lipid peroxidation, thereby proving it to be an effective cytoprotectant.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1983 Feb;43(2):460-72 - PubMed
    1. Hum Exp Toxicol. 1995 Jun;14(6):484-8 - PubMed
    1. Pharmacol Toxicol. 2000 May;86(5):234-41 - PubMed
    1. Reprod Toxicol. 1988;2(2):117-26 - PubMed
    1. Biochim Biophys Acta. 1969 Jul 8;185(1):39-48 - PubMed

Publication types

MeSH terms

LinkOut - more resources